GlassScriptPhysician profile
Emma J Cordes
NPI 1699195487
$5,204.47
in general payments reported to CMS, 2019-2025
7 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.00 · 2022: $273 · 2023: $4,256 · 2024: $428 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $2,088 · Food and Beverage: $1,444 · Travel and Lodging: $1,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $2,088.00 |
| Food and Beverage | $1,444.09 |
| Travel and Lodging | $1,300.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $2,657.24 | 2021-2024 | Blade, Sterile, Microtia, Cartilage, Menezes, Scalpel, Qty: 001 Ea, Template, Ear Carving, Yamada and Harada, A54-1, 54 Mm, Titanium, Qty: 001 Ea, Template, Ear Carving, Yamada and Harada, A56-1, 56 Mm, Titanium, Qty: 001 Ea |
| Medical Device Business Services, INC. | $1,752.10 | 2023 | |
| Depuy Synthes Sales INC. | $346.07 | 2022-2023 | Na, Trumatch, Rapidsorb |
| Tela Bio, INC. | $160.08 | 2024 | Ovitex 2s |
| Innovation Technologies INC | $149.02 | 2025 | Irrisept |
| Polynovo North America LLC | $134.16 | 2024 | Novosorb Btm |
| Kerecis Limited | $5.80 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Cordes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.